Fin Trust Capital Advisors, LLC Repligen Corp Transaction History
Fin Trust Capital Advisors, LLC
- $577 Million
- Q3 2024
A detailed history of Fin Trust Capital Advisors, LLC transactions in Repligen Corp stock. As of the latest transaction made, Fin Trust Capital Advisors, LLC holds 35 shares of RGEN stock, worth $5,056. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35
Previous 39
10.26%
Holding current value
$5,056
Previous $4,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding RGEN
# of Institutions
488Shares Held
54.2MCall Options Held
341KPut Options Held
235K-
Black Rock Inc. New York, NY7.57MShares$1.09 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.39MShares$923 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$729 Million0.01% of portfolio
-
State Street Corp Boston, MA1.62MShares$235 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.42MShares$205 Million1.34% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.02B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....